Search
Returning search results with filters:
Remove filter for
Audience: Health professionals
Remove filter for
Category: Drugs
Remove filter for
Last updated: 2020
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2020
- December 20204 results available
- November 20201 results available
- October 20206 results available
- September 20205 results available
- August 20201 results available
- July 20204 results available
- June 20202 results available
- May 20207 results available
- April 20206 results available
- March 20202 results available
Displaying 31 - 38 of 38 items.
Importation of US-Labelled Vecuronium Bromide for Injection due to Shortage of Neuromuscular Blocker Products
AlertHealth professional risk communication | 2020-04-29
Importation of US-Labelled QUELICIN (succinylcholine chloride injection) due to Shortage of Canadian-labelled QUELICIN
AlertHealth professional risk communication | 2020-04-29
Importation of US-Labelled Rocuronium Bromide Injection Due to Shortage of Canadian-labelled Rocuronium
AlertHealth professional risk communication | 2020-04-29
Importation of US-Labelled Pancuronium Bromide Injection Due to Shortage of Neuromuscular Blocker Products
AlertHealth professional risk communication | 2020-04-29
Chloroquine and hydroxychloroquine can have serious side effects. These drugs should be used only under the supervision of a physician.
AlertInformation update | 2020-04-25
Methadone Treatment of Opioid Dependence and Potential Differences in Product Effect
AlertHealth professional risk communication | 2020-03-31
No scientific evidence that ibuprofen worsens COVID-19 symptoms
AlertInformation update | 2020-03-20